DS7300-188
You are invited to participate in the Daiichi Sankyo - DS7300-188 study.
Developer: Medable Inc.
App Size: Varies With Device
Release Date: Apr 22, 2024
Price: Free
Medical
DS7300-188
Screenshots for App
Mobile
A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.
More Information about: DS7300-188
Price:
Free
Version:
5.5.700.5-prod
Downloads:
46
Compatibility:
Android 8.0
Bundle Id:
com.medable.ds7300188
Size:
Varies With Device
Last Update:
2024-07-23
Content Rating:
Everyone
Release Date:
Apr 22, 2024
Content Rating:
Everyone
Developer:
Medable Inc.
Developer Apps
Latest Apps & Games